S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
All the trading advice you’ve ever received boils down to this (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
All the trading advice you’ve ever received boils down to this (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
All the trading advice you’ve ever received boils down to this (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
All the trading advice you’ve ever received boils down to this (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
All the trading advice you’ve ever received boils down to this (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
All the trading advice you’ve ever received boils down to this (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
All the trading advice you’ve ever received boils down to this (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
All the trading advice you’ve ever received boils down to this (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months

Johnson & Johnson (JNJ) Stock Price, News & Analysis

$154.42
-0.98 (-0.63%)
(As of 12/8/2023 08:57 PM ET)
Compare
Today's Range
$153.84
$155.85
50-Day Range
$145.62
$158.85
52-Week Range
$144.95
$181.04
Volume
6.25 million shs
Average Volume
11.44 million shs
Market Capitalization
$371.73 billion
P/E Ratio
11.46
Dividend Yield
3.08%
Price Target
$170.19

Johnson & Johnson MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
10.2% Upside
$170.19 Price Target
Short Interest
Healthy
0.55% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.98
Upright™ Environmental Score
News Sentiment
0.32mentions of Johnson & Johnson in the last 14 days
Based on 48 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
7.37%
From $10.04 to $10.78 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.19 out of 5 stars

Medical Sector

15th out of 941 stocks

Pharmaceutical Preparations Industry

6th out of 426 stocks


JNJ stock logo

About Johnson & Johnson Stock (NYSE:JNJ)

Johnson & Johnson is a US-based multinational pharmaceutical company that started in the early 1870s. Robert Wood Johnson began training as a pharmacist at 16 and founded his 1st company in 1873. That company would be disbanded by 1886 when Johnson joined his brothers to form today's entity. The company’s first line of products was sterile surgical dressings which were soon followed up by household products and medical guides.

Today, Johnson & Johnson is one of the world’s largest companies. It is ranked 36th on the 2021 Fortune 500 list and is a Dow Jones Industrial Average member. The company operates via 250 subsidiaries with operations in 60 countries and product sales in 175. As of 2021, annual sales were in the range of $95 billion and growing. The company is also a leader in equality and the advancement of women’s rights. Johnson & Johnson’s workforce was nearly 50% female by 1910, and many held significant positions of responsibility.

Among the company’s many advances in health care is the advancement of sterile conditions to prevent postoperative and secondary infections. Products include sterile gauze, cotton and dressings, and the development of the industrial sterilization process. However, the product that launched the company to success was the combination of a sterile dressing with tape. The company called the new products Band-Aids, which is now synonymous with small, prepackaged bandages. Another major win for the company was Johnson & Johnson Baby Soap.

Today, Johnson & Johnson operates in 3 segments: Pharmaceutical, Consumer Health and MedTech. The Consumer Health segment alone covers brands like Aveeno, Listerine, Tylenol, Zyrtec, Band-Aid and Neosporin, which are among the world’s most recognizable brands. The company’s purpose is to “blend science and ingenuity to change the trajectory of health for humanity profoundly”.

The Pharmaceutical segment offers products in all segments of the healthcare spectrum and has partnerships to develop new drugs with at least 10 other major healthcare providers and dozens of smaller research facilities. Products are offered wholesale to retailers and through healthcare systems. The MedTech segment develops and manufactures various healthcare devices and diagnostic tools. Among the many recognizable products from this segment are ACUVUE contact lenses.

Johnson & Johnson went public in 1944 and began paying dividends soon after. The company began increasing its dividend payment in 1962 and has increased it yearly. The company is a member of the Dividend Aristocrat Index and qualifies as a Dividend King with more than 50 years of consecutive annual increases. The company employs more than 142,000 individuals and serves more than 1 billion daily. Regarding the company’s health, its track record of dividend payments is backed up by a AAA credit rating. Johnson & Johnson is one of only 2 US corporations with such a rating and is more trusted than the US government.

The company announced plans to split into two publicly traded companies in 2021. The move is expected to be complete in late 2023 and will result in a Consumer Health company and a Pharmaceutical company.





JNJ Stock Price History

JNJ Stock News Headlines

Is Amazon a blue chip stock? (JNJ)
Is Amazon a blue chip stock or does it fit into a different category? Learn more about Amazon.com Inc. and how to categorize it with MarketBeat.
Johnson & Johnson’s prescription for growth
J&J projects 5-6% revenue growth in 2024, fueled by strong core businesses, acquisitions, and a robust pipeline targeting $57 billion in drug sales by 2025.
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts (JNJ)
No matter which holiday you're planning gifts for, Christmas, Hanukkah, or some other occasion, there may be one great gift idea you haven't thought of yet.
Are blue chip stocks a good investment? (JNJ)
Are blue chip stocks a good investment? Are there other investments you should consider in addition to or before blue chips? Learn more with MarketBeat.
J&J, Gilead, BMS: A look at undervalued dividend payers (JNJ)
J&J, Gilead and Bristol Myers are among healthcare stocks with defensive qualities amid market volatility and a potential economic slowdown
2023's most anticipated IPOs weren't always the big winners (JNJ)
146 U.S. companies went public in 2023, down 16.09% from last year. Despite market ups and downs, the Renaissance index of IPOs is outperforming the S&P 500
Teva Pharma is the way to play the re-rise of generic drugs (JNJ)
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Buffett's latest portfolio additions, trims and cuts in Q3 (JNJ)
Buffett's Berkshire latest Q3 moves: Acquires Sirius XM, Atlanta Braves; trims HP, Chevron, Amazon; holds onto Apple, Bank of America.
J&J (JNJ) Announces 2024 and Long-Term Financial Outlook
Johnson & Johnson Slides on Growth Projections
See More Headlines
Receive JNJ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Johnson & Johnson and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/17/2023
Ex-Dividend for 12/5 Dividend
11/20/2023
Dividend Payable
12/05/2023
Today
12/10/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
1/23/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
CUSIP
47816010
Employees
155,800
Year Founded
1886

Price Target and Rating

Average Stock Price Target
$170.19
High Stock Price Target
$215.00
Low Stock Price Target
$52.00
Potential Upside/Downside
+10.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
14 Analysts

Profitability

Net Income
$17.94 billion
Pretax Margin
16.88%

Debt

Sales & Book Value

Annual Sales
$94.94 billion
Cash Flow
$12.93 per share
Book Value
$29.39 per share

Miscellaneous

Outstanding Shares
2,407,280,000
Free Float
2,402,464,000
Market Cap
$371.73 billion
Optionable
Optionable
Beta
0.57

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Should I Buy Johnson & Johnson Stock? JNJ Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Johnson & Johnson was last updated on Sunday, December 10, 2023 at 7:11 PM.

Pros

Here are some ways that investors could benefit from investing in Johnson & Johnson:

  • Johnson & Johnson is a well-established company in the healthcare field, with a history dating back to 1886.
  • The company offers a diverse range of products in the healthcare sector, including pharmaceuticals, consumer health products, and medical devices.
  • Johnson & Johnson's pharmaceutical segment provides products for various medical conditions, including rheumatoid arthritis, cancer, and infectious diseases.
  • The company has a strong presence in the consumer health market, offering popular brands such as NEUTROGENA, LISTERINE, and TYLENOL.
  • Johnson & Johnson has a global reach, serving customers worldwide and benefiting from international markets.

Cons

Investors should be bearish about investing in Johnson & Johnson for these reasons:

  • The stock price of Johnson & Johnson may be subject to fluctuations in the healthcare industry and overall market conditions.
  • Regulatory challenges and legal issues related to product safety and liability could impact the company's financial performance.
  • Competition in the healthcare sector is intense, and Johnson & Johnson faces competition from both established players and emerging companies.
  • The company's financial performance may be affected by factors such as changes in healthcare policies, reimbursement rates, and pricing pressures.
  • Investors should carefully consider the potential risks and uncertainties associated with investing in the pharmaceutical and healthcare industries.














JNJ Stock Analysis - Frequently Asked Questions

Should I buy or sell Johnson & Johnson stock right now?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last year. There are currently 7 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" JNJ shares.
View JNJ analyst ratings
or view top-rated stocks.

What is Johnson & Johnson's stock price target for 2024?

14 brokerages have issued twelve-month price targets for Johnson & Johnson's shares. Their JNJ share price targets range from $52.00 to $215.00. On average, they predict the company's share price to reach $170.19 in the next year. This suggests a possible upside of 10.2% from the stock's current price.
View analysts price targets for JNJ
or view top-rated stocks among Wall Street analysts.

How have JNJ shares performed in 2023?

Johnson & Johnson's stock was trading at $176.65 on January 1st, 2023. Since then, JNJ stock has decreased by 12.6% and is now trading at $154.42.
View the best growth stocks for 2023 here
.

Are investors shorting Johnson & Johnson?

Johnson & Johnson saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 13,190,000 shares, a decrease of 9.2% from the October 31st total of 14,530,000 shares. Based on an average daily volume of 7,410,000 shares, the days-to-cover ratio is currently 1.8 days. Approximately 0.6% of the company's stock are short sold.
View Johnson & Johnson's Short Interest
.

When is Johnson & Johnson's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, January 23rd 2024.
View our JNJ earnings forecast
.

How were Johnson & Johnson's earnings last quarter?

Johnson & Johnson (NYSE:JNJ) released its quarterly earnings data on Tuesday, October, 17th. The company reported $2.66 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.52 by $0.14. The company had revenue of $21.35 billion for the quarter, compared to analysts' expectations of $21 billion. Johnson & Johnson had a trailing twelve-month return on equity of 37.14% and a net margin of 36.32%.

How often does Johnson & Johnson pay dividends? What is the dividend yield for Johnson & Johnson?

Johnson & Johnson announced a quarterly dividend on Thursday, October 19th. Shareholders of record on Tuesday, November 21st will be paid a dividend of $1.19 per share on Tuesday, December 5th. This represents a $4.76 dividend on an annualized basis and a dividend yield of 3.08%. The ex-dividend date of this dividend is Monday, November 20th.
Read our dividend analysis for JNJ
.

Is Johnson & Johnson a good dividend stock?

Johnson & Johnson (NYSE:JNJ) pays an annual dividend of $4.76 per share and currently has a dividend yield of 3.06%. The company has been increasing its dividend for 61 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 35.34%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, JNJ will have a dividend payout ratio of 44.16% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for JNJ.

How will Johnson & Johnson's stock buyback program work?

Johnson & Johnson announced that its Board of Directors has authorized a share buyback program on Wednesday, September 14th 2022, which permits the company to buyback $5,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 1.2% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's leadership believes its shares are undervalued.

What guidance has Johnson & Johnson issued on next quarter's earnings?

Johnson & Johnson updated its FY24 earnings guidance on Tuesday, December, 5th. The company provided EPS guidance of $10.55-10.75 for the period, compared to the consensus EPS estimate of $10.78.

What is Alex Gorsky's approval rating as Johnson & Johnson's CEO?

2,535 employees have rated Johnson & Johnson Chief Executive Officer Alex Gorsky on Glassdoor.com. Alex Gorsky has an approval rating of 94% among the company's employees. This puts Alex Gorsky in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Johnson & Johnson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Johnson & Johnson investors own include AT&T (T), Pfizer (PFE), Verizon Communications (VZ), Walt Disney (DIS), NVIDIA (NVDA), Intel (INTC), JPMorgan Chase & Co. (JPM), Cisco Systems (CSCO), Procter & Gamble (PG) and AbbVie (ABBV).

Who are Johnson & Johnson's major shareholders?

Johnson & Johnson's stock is owned by many different retail and institutional investors. Top institutional shareholders include Morgan Stanley (1.71%), Northern Trust Corp (1.26%), Bank of New York Mellon Corp (0.84%), Wellington Management Group LLP (0.86%), Legal & General Group Plc (0.75%) and FMR LLC (0.74%). Insiders that own company stock include Ashley Mcevoy, James D Swanson, Jennifer L Taubert, Joseph J Wolk, Kathryn E Wengel, Peter Fasolo, Robert J Decker, Thibaut Mongon and William Hait.
View institutional ownership trends
.

How do I buy shares of Johnson & Johnson?

Shares of JNJ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Does Johnson & Johnson have any subsidiaries?
The following companies are subsidiares of Johnson & Johnson: 3Dintegrated ApS, ALZA Corporation, AMO (Hangzhou) Co. Ltd., AMO (Shanghai) Medical Devices Trading Co. Ltd Beijing Branch, AMO (Shanghai) Medical Devices Trading Co. Ltd Guangzhou Branch, AMO (Shanghai) Medical Devices Trading Co. Ltd., AMO ASIA LIMITED, AMO Asia Limited (Korea Branch), AMO Asia Limited Taiwan Branch (Hong Kong), AMO Australia Pty Limited, AMO Australia Pty Limited (New Zealand Branch), AMO Canada Company, AMO Denmark ApS, AMO Development LLC, AMO France, AMO Germany GmbH, AMO Groningen B.V., AMO International Holdings Unlimited Company, AMO Ireland, AMO Ireland Ireland Branch, AMO Italy SRL, AMO Japan K.K., AMO Manufacturing USA LLC, AMO Netherlands BV, AMO Nominee Holdings LLC, AMO Norway AS, AMO Puerto Rico Manufacturing Inc., AMO Sales and Service Inc., AMO Singapore Pte. Ltd., AMO Spain Holdings LLC, AMO Switzerland GmbH, AMO U.K. Holdings LLC, AMO United Kingdom Ltd., AMO Uppsala AB, AUB Holdings LLC, Abott Medical Optics, Acclarent Inc., Actelion Ltd, Actelion Pharmaceuticals, Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd., Actelion Pharmaceuticals US Inc., Actelion Treasury Unlimited Company, Akros Medical Inc., Albany Street LLC, Alios BioPharma, Alza Land Management Inc., Anakuria Therapeutics Inc., Animas Diabetes Care LLC, Animas LLC, Animas Technologies LLC, AorTx Inc., Apsis, Aragon Pharmaceuticals, Aragon Pharmaceuticals Inc., Asia Pacific Holdings LLC, Atrionix Inc., Auris Health, Auris Health Inc., Backsvalan 2 Aktiebolag, Backsvalan 6 Handelsbolag, Beijing Dabao Cosmetics Co. Ltd., BeneVir BioPharm Inc., Berna Rhein B.V., BioMedical Enterprises Inc., Biosense Webster (Israel) Ltd., Biosense Webster Inc., Branch of Johnson & Johnson LLC (RU) in Kazakhstan, C Consumer Products Denmark ApS, CSATS Inc., Calibra Medical LLC, Campus-Foyer Apotheke GmbH, Carlo Erba OTC S.r.l., Centocor Biologics LLC, Centocor Research & Development Inc., Cerenovus Inc., ChromaGenics B.V., Ci:Labo Customer Marketing Co. Ltd., Ci:Labo USA Inc., Ci:z Holdings, Ci:z. Labo Co. Ltd., Cilag AG, Cilag GmbH International, Cilag Holding AG, Cilag Holding Treasury Unlimited Company, Cilag-Biotech S.L., CoTherix Inc., Coherex Medical Inc., ColBar LifeScience Ltd., Company Store.com Inc., Conor MedSystems, Cordis International Corporation, Cordis de Mexico S.A. de C.V., Corimmun GmbH, DePuy Hellas SA, DePuy International Limited, DePuy Ireland Unlimited Company, DePuy Mexico S.A. de C.V., DePuy Mitek LLC, DePuy Orthopaedics Inc., DePuy Products Inc., DePuy Spine LLC, DePuy Synthes Gorgan Limited, DePuy Synthes Inc., DePuy Synthes Institute LLC, DePuy Synthes Leto SARL, DePuy Synthes Products Inc., DePuy Synthes Sales Inc., Debs-Vogue Corporation (Proprietary) Limited, Dutch Holding LLC, ECL7 LLC, EES Holdings de Mexico S. de R.L. de C.V., EES S.A. de C.V., EIT Emerging Implant Technologies GmbH, Ethicon Endo-Surgery (Europe) GmbH, Ethicon Endo-Surgery Inc., Ethicon Endo-Surgery LLC, Ethicon Inc., Ethicon LLC, Ethicon PR Holdings Unlimited Company, Ethicon Sarl, Ethicon US LLC, Ethicon Women's Health & Urology Sarl, Ethnor (Proprietary) Limited, Ethnor Farmaceutica S.A., Ethnor del Istmo S.A., FMS Future Medical System SA, Finsbury (Development) Limited, Finsbury (Instruments) Limited, Finsbury Medical Limited, Finsbury Orthopaedics International Limited, Finsbury Orthopaedics Limited, GH Biotech Holdings Limited, GMED Healthcare BV, GMED Healthcare BV (Branch), Global Investment Participation B.V., Guangzhou Bioseal Biotech Co. Ltd., Hansen Medical Deutschland GmbH, Hansen Medical Inc., Hansen Medical International Inc., Hansen Medical UK Limited, Healthcare Services (Shanghai) Ltd., Hickory Merger Sub Inc., I.D. Acquisition Corp., Innomedic Gesellschaft für innovative Medizintechnik und Informatik mbH, Innovative Surgical Solutions LLC, J & J Company West Africa Limited, J&J Pension Trustees Limited, J-C Health Care Ltd., J.C. General Services BV, JJ Surgical Vision Spain S.L., JJC Acquisition Company B.V., JJHC LLC, JJSV Belgium BV, JJSV Manufacturing Malaysia SDN. BHD., JJSV Norden AB, JJSV Produtos Oticos Ltda., JNJ Global Business Services s.r.o., JNJ Holding EMEA B.V., JNJ International Investment LLC, JOM Pharmaceutical Services Inc., Janssen Alzheimer Immunotherapy (Holding) Limited, Janssen BioPharma LLC, Janssen Biologics (Ireland) Limited, Janssen Biologics B.V., Janssen Biotech Inc., Janssen Cilag C.A., Janssen Cilag Farmaceutica S.A., Janssen Cilag S.p.A., Janssen Cilag SPA, Janssen Development Finance Unlimited Company, Janssen Diagnostics LLC, Janssen Egypt LLC, Janssen Farmaceutica Portugal Lda, Janssen Global Services LLC, Janssen Holding GmbH, Janssen Inc., Janssen Irish Finance Unlimited Company, Janssen Korea Ltd., Janssen Oncology Inc., Janssen Ortho LLC, Janssen Pharmaceutica (Proprietary) Limited, Janssen Pharmaceutica NV, Janssen Pharmaceutica S.A., Janssen Pharmaceutical K.K., Janssen Pharmaceutical Sciences Unlimited Company, Janssen Pharmaceutical Unlimited Company, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals Inc. Japan Branch, Janssen Products LP, Janssen R&D Ireland Unlimited Company, Janssen Research & Development LLC, Janssen Sciences Ireland Unlimited Company, Janssen Scientific Affairs LLC, Janssen Supply Group LLC, Janssen Vaccines & Prevention B.V., Janssen Vaccines Branch of Cilag GmbH International, Janssen Vaccines Corp., Janssen-Cilag, Janssen-Cilag (New Zealand) Limited, Janssen-Cilag A/S, Janssen-Cilag AG, Janssen-Cilag AS, Janssen-Cilag Aktiebolag, Janssen-Cilag B.V., Janssen-Cilag Farmaceutica Lda., Janssen-Cilag Farmaceutica Ltda., Janssen-Cilag GmbH, Janssen-Cilag International NV, Janssen-Cilag Kft., Janssen-Cilag Kft. Branch Office, Janssen-Cilag Limited, Janssen-Cilag Manufacturing LLC, Janssen-Cilag NV, Janssen-Cilag OY, Janssen-Cilag Pharma GmbH, Janssen-Cilag Pharmaceutical S.A.C.I., Janssen-Cilag Polska Sp. z o.o., Janssen-Cilag Pty Ltd, Janssen-Cilag Pty Ltd (Branch), Janssen-Cilag S.A., Janssen-Cilag S.A., Janssen-Cilag S.A. de C.V., Janssen-Cilag de Mexico S. de R.L. de C.V., Janssen-Cilag s.r.o., Janssen-Pharma S.L., Jevco Holding Inc., Johnson & Johnson, Johnson & Johnson (Angola) Limitada, Johnson & Johnson (China) Investment Ltd., Johnson & Johnson (China) Investment Ltd. Beijing Branch, Johnson & Johnson (Egypt) S.A.E., Johnson & Johnson (Hong Kong) Limited, Johnson & Johnson (Ireland) Limited, Johnson & Johnson (Jamaica) Limited, Johnson & Johnson (Kenya) Limited, Johnson & Johnson (Middle East) Inc., Johnson & Johnson (Middle East) Inc. (DHCC Branch), Johnson & Johnson (Middle East) Inc. (JAFZA Branch), Johnson & Johnson (Middle East) Inc. Service Center (DAFZA Branch), Johnson & Johnson (Mozambique) Limitada, Johnson & Johnson (Namibia) (Proprietary) Limited, Johnson & Johnson (New Zealand) Limited, Johnson & Johnson (Philippines) Inc., Johnson & Johnson (Private) Limited, Johnson & Johnson (Thailand) Ltd., Johnson & Johnson (Trinidad) Limited, Johnson & Johnson (Vietnam) Co. Ltd, Johnson & Johnson - Societa' Per Azioni, Johnson & Johnson AB, Johnson & Johnson AB Eesti filiaal (Branch), Johnson & Johnson AG, Johnson & Johnson AG (Zuchwil Branch), Johnson & Johnson Belgium Finance Company BV, Johnson & Johnson Bulgaria EOOD, Johnson & Johnson China Ltd., Johnson & Johnson Consumer (Hong Kong) Limited, Johnson & Johnson Consumer (Thailand) Limited, Johnson & Johnson Consumer B.V., Johnson & Johnson Consumer Health Care Switzerland Branch of Janssen-Cilag AG, Johnson & Johnson Consumer Holdings France, Johnson & Johnson Consumer Inc., Johnson & Johnson Consumer Inc. (Dominican Republic Branch), Johnson & Johnson Consumer NV, Johnson & Johnson Consumer Saudi Arabia Limited, Johnson & Johnson Consumer Services EAME Ltd., Johnson & Johnson Del Paraguay S.A., Johnson & Johnson Dominicana S.A.S., Johnson & Johnson Enterprise Innovation Inc., Johnson & Johnson European Treasury Unlimited Company, Johnson & Johnson Finance Corporation, Johnson & Johnson Finance Limited, Johnson & Johnson Financial Services GmbH, Johnson & Johnson Financial Services GmbH (Branch Office), Johnson & Johnson Gateway LLC, Johnson & Johnson Gesellschaft m.b.H., Johnson & Johnson GmbH, Johnson & Johnson Guatemala S.A., Johnson & Johnson Health Care Systems Inc., Johnson & Johnson Health and Wellness Solutions Inc., Johnson & Johnson Hellas Commercial and Industrial S.A., Johnson & Johnson Hellas Consumer Products Commercial Societe Anonyme, Johnson & Johnson Hemisferica S.A., Johnson & Johnson Holding GmbH, Johnson & Johnson Inc., Johnson & Johnson Industrial Ltda., Johnson & Johnson Innovation - JJDC Inc., Johnson & Johnson Innovation LLC, Johnson & Johnson Innovation Limited, Johnson & Johnson International, Johnson & Johnson International (Belgian Branch) (European Logistics Center), Johnson & Johnson International (Singapore) Pte. Ltd., Johnson & Johnson International (Singapore) Pte. Ltd. (Branch), Johnson & Johnson International Financial Services Unlimited Company, Johnson & Johnson K.K., Johnson & Johnson Kft., Johnson & Johnson Korea Ltd., Johnson & Johnson Korea Selling & Distribution LLC, Johnson & Johnson LLC, Johnson & Johnson Lda, Johnson & Johnson Limited, Johnson & Johnson Limited (Sri Lanka Branch), Johnson & Johnson Luxembourg Finance Company Sarl, Johnson & Johnson Management Limited, Johnson & Johnson Medical (China) Ltd., Johnson & Johnson Medical (Proprietary) Ltd, Johnson & Johnson Medical (Shanghai) Ltd., Johnson & Johnson Medical (Shanghai) Ltd. Beijing Branch, Johnson & Johnson Medical (Suzhou) Ltd., Johnson & Johnson Medical B.V., Johnson & Johnson Medical Devices & Diagnostics Group - Latin America L.L.C., Johnson & Johnson Medical GmbH, Johnson & Johnson Medical Korea Ltd., Johnson & Johnson Medical Limited, Johnson & Johnson Medical Mexico S.A. de C.V., Johnson & Johnson Medical NV, Johnson & Johnson Medical Products GmbH, Johnson & Johnson Medical Pty Ltd, Johnson & Johnson Medical S.A., Johnson & Johnson Medical S.C.S., Johnson & Johnson Medical S.p.A., Johnson & Johnson Medical SAS, Johnson & Johnson Medical Saudi Arabia Limited, Johnson & Johnson Medical Taiwan Ltd., Johnson & Johnson Medikal Sanayi ve Ticaret Limited Sirketi, Johnson & Johnson Medikal Sanayi ve Ticaret Limited Sirketi (Ankara Branch), Johnson & Johnson Medikal Sanayi ve Ticaret Limited Sirketi (Izmir Branch), Johnson & Johnson Middle East - Scientific Office, Johnson & Johnson Middle East FZ - LLC (Lebanese Branch), Johnson & Johnson Middle East FZ-LLC, Johnson & Johnson Middle East FZ-LLC (Ghana Branch), Johnson & Johnson Middle East FZ-LLC (Kenya Branch), Johnson & Johnson Middle East FZ-LLC Branch (TSO) (Saudi Arabia Branch), Johnson & Johnson Morocco Societe Anonyme, Johnson & Johnson NCB (Belgian Branch), Johnson & Johnson Nordic AB, Johnson & Johnson Pacific Pty Limited, Johnson & Johnson Pakistan (Private) Limited, Johnson & Johnson Panama S.A., Johnson & Johnson Personal Care (Chile) S.A., Johnson & Johnson Poland Sp. z o.o., Johnson & Johnson Poland sp. z o.o. oddzial w Warszawie "Consumer", Johnson & Johnson Private Limited, Johnson & Johnson Pte. Ltd., Johnson & Johnson Pte. Ltd. Korea Branch, Johnson & Johnson Pty. Limited, Johnson & Johnson Romania S.R.L., Johnson & Johnson S.A., Johnson & Johnson S.A. de C.V., Johnson & Johnson S.E. Inc., Johnson & Johnson S.E. d.o.o., Johnson & Johnson SDN. BHD., Johnson & Johnson Sante Beaute France, Johnson & Johnson Services Inc., Johnson & Johnson Surgical Vision Inc., Johnson & Johnson Surgical Vision India Private Limited, Johnson & Johnson Taiwan Ltd., Johnson & Johnson UK Treasury Company Limited, Johnson & Johnson Ukraine LLC, Johnson & Johnson Urban Renewal Associates, Johnson & Johnson Vision Care (Shanghai) Ltd., Johnson & Johnson Vision Care Inc., Johnson & Johnson Vision Care Ireland Unlimited Company, Johnson & Johnson d.o.o., Johnson & Johnson de Argentina S.A.C. e. I., Johnson & Johnson de Chile Limitada, Johnson & Johnson de Chile S.A., Johnson & Johnson de Colombia S.A., Johnson & Johnson de Mexico S.A. de C.V., Johnson & Johnson de Uruguay S.A., Johnson & Johnson de Venezuela S.A., Johnson & Johnson del Ecuador S.A., Johnson & Johnson del Peru S.A., Johnson & Johnson do Brasil Industria E Comercio de Produtos Para Saude Ltda., Johnson & Johnson for Export and Import LLC, Johnson & Johnson s.r.o., Johnson Y Johnson de Costa Rica S.A., Johnson and Johnson (Proprietary) Limited, Johnson and Johnson Sihhi Malzeme Sanayi Ve Ticaret Limited Sirketi, LTL Management LLC, La Concha Land Investment Corporation, Latam International Investment Company Unlimited Company, Legal Entity Name, MDS Co. Ltd., McNEIL MMP LLC, McNeil AB, McNeil Consumer Pharmaceuticals Co., McNeil Denmark ApS, McNeil Healthcare (Ireland) Limited, McNeil Healthcare (UK) Limited, McNeil Healthcare LLC, McNeil Iberica S.L.U., McNeil LA LLC, McNeil Nutritionals LLC, McNeil Panama LLC, McNeil Products Limited, McNeil Sweden AB, Medical Device Business Services Inc., Medical Devices & Diagnostics Global Services LLC, Medical Devices International LLC, Medos International Sarl, Medos International Sàrl succursale de Neuchâtel (Branch), Medos Sarl, MegaDyne Medical Products Inc., Menlo Care De Mexico S.A. de C.V., Mentor B.V., Mentor Deutschland GmbH, Mentor Medical Systems B.V., Mentor Partnership Holding Company I LLC, Mentor Texas GP LLC, Mentor Texas L.P., Mentor Worldwide LLC, Micrus Endovascular LLC, Middlesex Assurance Company Limited, Momenta Ireland Limited, Momenta Pharmaceuticals, Momenta Pharmaceuticals Inc., NeoStrata Company Inc., NeoStrata UG (haftungsbeschränkt), Netherlands Holding Company, NeuWave Medical Inc., Neuravi Limited, Novira Therapeutics, Novira Therapeutics LLC, NuVera Medical Inc., OBTECH Medical Sarl, OGX Beauty Limited, OMJ Holding GmbH, OMJ Ireland Unlimited Company, OMJ Pharmaceuticals Inc., Obtech Medical Mexico S.A. de C.V., Omrix Biopharmaceuticals Inc., Omrix Biopharmaceuticals Ltd., Omrix Biopharmaceuticals NV, Ortho Biologics LLC, Ortho Biotech Holding LLC, Ortho-McNeil Pharmaceutical LLC, Orthospin Ltd., Orthotaxy, PT Integrated Healthcare Indonesia, PT. Johnson & Johnson Indonesia, Patriot Pharmaceuticals LLC, Peninsula Pharmaceuticals LLC, Pharmadirect Ltd., Pharmedica Laboratories (Proprietary) Limited, Princeton Laboratories Inc., Productos de Cuidado Personal y de La Salud de Bolivia S.R.L., Proleader S.A., Pulsar Vascular Inc., Regency Urban Renewal Associates, RespiVert Ltd., RoC International, Royalty A&M LLC, Rutan Realty LLC, SYNTHES Medical Immobilien GmbH, Scios LLC, Sedona Singapore International Pte. Ltd., Sedona Thai International Co. Ltd., Serhum S.A. de C.V., Shanghai Elsker For Mother & Baby Co. Ltd, Shanghai Elsker Mother & Baby Co. Ltd Minghang Branch, Shanghai Johnson & Johnson Ltd., Shanghai Johnson & Johnson Pharmaceuticals Ltd., Sightbox LLC, Sodiac ESV, Spectrum Vision Limited Liability Company, Spectrum Vision Limited Liability Partnership, SterilMed, SterilMed Inc., Surgical Process Institute Deutschland GmbH, Synthes Costa Rica S.C.R. Limitada, Synthes GmbH, Synthes Holding AG, Synthes Holding Limited, Synthes Inc., Synthes Medical Surgical Equipment & Instruments Trading LLC, Synthes Produktions GmbH, Synthes Proprietary Limited, Synthes S.M.P. S. de R.L. de C.V., Synthes Tuttlingen GmbH, Synthes USA LLC, Synthes USA Products LLC, TARIS Biomedical, TARIS Biomedical LLC, TearScience Inc., The Anspach Effort LLC, The Vision Care Institute LLC, Tibotec LLC, Torax Medical Inc., UAB "Johnson & Johnson", UAB Johnson & Johnson Eesti Filiaal (Estonian Branch), Vania Expansion, Verb Surgical, Verb Surgical Inc., Vision Care Finance Unlimited Company, Vogue International, Vogue International LLC, Vogue International Trading Inc., WH4110 Development Company L.L.C., XO1, XO1 Limited, Xian Janssen Pharmaceutical Ltd., Xian-Janssen Pharmaceutical Ltd. Beijing Branch Office, Xian-Janssen Pharmaceutical Ltd. Shanghai Branch Office, Zarbee's Inc., and Zarbee's Naturals.
Read More
This page (NYSE:JNJ) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -